Swine fever vaccines play a crucial role in protecting swine from African swine fever. The recombinant vaccine technology offers enhanced disease protection with fewer side effects for swine. Recombinant vaccines are produced from genetically engineered viruses that cannot cause disease but can still induce strong immune responses. This allows for consistent large-scale manufacturing of safe and effective swine fever vaccines.
The global SWINE FEVER VACCINE MARKET is estimated to be valued at US$ 3323.81 BN in 2024 and is expected to exhibit a CAGR OF 11% over the forecast period 2024 TO 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The adoption of recombinant vaccine technology is accelerating growth in the swine fever vaccine market. Recombinant vaccines produce antigens that closely mimic those produced during natural infection, inducing robust immunity without risk of disease transmission. This enables mass vaccination of pig populations. Manufacturers are focusing on development of recombinant vaccines as an alternative to conventional modified live vaccines. For instance, in 2017, Agricola Biologicals received approval from Indian regulatory authorities for its E2 subunit recombinant vaccine. Such approvals are boosting the availability of advanced recombinant vaccines globally. Widespread usage of recombinant vaccines can help control the spread of African swine fever outbreaks efficiently.
Segment Analysis
The global swine fever vaccine market is segmented on the basis of product type, disease type, end user and region. By product type, the modified live vaccines segment dominated market in 2024 as these vaccines provide strong immunity against swine fever infection and have high effectiveness rates. By disease type, the classical swine fever segment accounted for largest share as classical swine fever is highly contagious among pigs. By end user, the veterinary hospitals and diagnostic laboratories segment was leading segment owing to increasing number of veterinary practices and prevalence of swine fever.
Key Takeaways
The Global Swine Fever Vaccine Market Demand is expected to witness high growth.
Regional analysis –
Asia Pacific is the fastest growing and dominating region in the global swine fever vaccine market. China accounts for a major share in Asia Pacific swine fever vaccine market as China is world's largest pork producer and consumer.
Key players operating in the swine fever vaccine market are dbWatch AS, eG Innovations, Heroix Corporation, Nagios Enterprises, LLC, Paessler AG, Quest Software Inc., Red Gate Software Ltd., Sematext Group, SolarWinds Worldwide, LLC, and VirtualMetric. These players have adopted various strategies to increase their market penetration and strengthen their position in the industry.
Get more insights on this topic :
Comments
0 comment